Livzon Pharmaceutical Reports Mixed Q3 2024 Financial Results
Company Announcements

Livzon Pharmaceutical Reports Mixed Q3 2024 Financial Results

Livzon Pharmaceutical Group (HK:1513) has released an update.

Livzon Pharmaceutical Group’s financial report for the third quarter of 2024 reveals a slight decline in operating income by 5.59% year-on-year, while net profit attributable to shareholders increased by 7.45%. The company’s basic earnings per share rose by 8%, indicating a steady performance amidst the challenging market conditions.

For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical Proposes New Non-Executive Director
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical Group Plans Key Meeting for 2024
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App